| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10620-018-4909-7 |
| P698 | PubMed publication ID | 29327261 |
| P50 | author | Ignazio R Marino | Q57069999 |
| P2093 | author name string | Augusto Lauro | |
| Mihai Oltean | |||
| P2860 | cites work | Combined liver and pancreas transplantation induces pancreas allograft tolerance | Q73278677 |
| "Tolerogenic effect" of the liver for a small bowel allograft | Q73285825 | ||
| Functional, histological, and inflammatory changes in chronically rejecting small bowel transplants | Q73613286 | ||
| Chronic rejection causes early destruction of the intrinsic nervous system in rat intestinal transplants | Q73644857 | ||
| Stress responses in graft and native intestine after rat heterotopic small bowel transplantation | Q73928291 | ||
| Infection-associated macrophage activation accelerates chronic renal allograft rejection in rats | Q73987360 | ||
| Increased expression of basic fibroblast growth factor during chronic rejection in intestinal transplants is associated with macrophage infiltrates | Q74611411 | ||
| Heat shock protein expression in the transplanted human kidney | Q77113865 | ||
| Increase of interleukin-6 in the intestinal mucosa and muscularis following chronic rejection after small bowel transplantation | Q77325344 | ||
| Evidence for heat shock protein immunity in a rat cardiac allograft model of chronic rejection | Q77916242 | ||
| Features of chronic allograft rejection on rat small intestine transplantation | Q79774413 | ||
| Inhibition of sonic hedgehog signaling reduces chronic rejection and prolongs allograft survival in a rat orthotopic small bowel transplantation model | Q80370926 | ||
| Short-term anti-CD4 plus anti-TNF-alpha receptor treatment in allogeneic small bowel transplantation results in long-term survival | Q81311574 | ||
| NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine | Q81508678 | ||
| Salvage therapy for refractory rejection and persistence of donor-specific antibodies after intestinal transplantation using the proteasome inhibitor bortezomib | Q82876388 | ||
| Combination therapy of tacrolimus and infliximab reduces inflammatory response and dysmotility in experimental small bowel transplantation in rats | Q82942284 | ||
| Intestinal ischemia reperfusion and lipopolysaccharide transform a tolerogenic signal into a sensitizing signal and trigger rejection | Q83882342 | ||
| Effects of immunosuppressive therapy after experimental small bowel transplantation in rats | Q84704222 | ||
| Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver | Q84932637 | ||
| Assessing the human gut microbiota in metabolic diseases | Q26860785 | ||
| Fish oil enhances recovery of intestinal microbiota and epithelial integrity in chronic rejection of intestinal transplant | Q27337413 | ||
| Short-term TNF-alpha inhibition reduces short-term and long-term inflammatory changes post-ischemia/reperfusion in rat intestinal transplantation | Q28577017 | ||
| Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells | Q30945115 | ||
| The role of proteasome inhibition with bortezomib in the treatment of antibody-mediated rejection after kidney-only or kidney-combined organ transplantation | Q33392607 | ||
| Combined liver-intestine grafts compared with isolated intestinal transplantation in children: a single-center experience | Q33403571 | ||
| Intestinal transplantation before and after the introduction of sirolimus. | Q34131258 | ||
| Monitoring and treatment of intestinal allograft rejection in humans | Q34248081 | ||
| Small-bowel allograft biopsies in the management of small-intestinal and multivisceral transplant recipients: histopathologic review and clinical correlations | Q34320060 | ||
| The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival | Q34421385 | ||
| Fibrogenesis in chronic allograft rejection: underlying mechanisms and pharmacological control | Q34996895 | ||
| Human gut microbiome adopts an alternative state following small bowel transplantation | Q35006562 | ||
| The effect of small bowel transplantation on the morphology and physiology of intestinal muscle: a comparison of autografts versus allografts in dogs | Q35160297 | ||
| Incidence, timing, and significance of early hypogammaglobulinemia after intestinal transplantation. | Q35298043 | ||
| Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts | Q35607413 | ||
| Effects of fish oil supplementation on kidney transplantation: a systematic review and meta-analysis of randomized, controlled trials | Q36164546 | ||
| Biologics in the treatment of transplant rejection and ischemia/reperfusion injury: new applications for TNFalpha inhibitors? | Q36243290 | ||
| Fish oil treatment for kidney transplant recipients: a meta-analysis of randomized controlled trials | Q36802300 | ||
| Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients. | Q36822826 | ||
| Heat shock protein 70 expression in native and heterotopically transplanted rat hearts | Q36874504 | ||
| Pediatric small bowel transplantation | Q37685511 | ||
| The use of sirolimus as a rescue therapy in pediatric intestinal transplant recipients | Q37800125 | ||
| Organ-specific solutions and strategies for the intestinal preservation | Q38170419 | ||
| Intestinal and multivisceral transplantation at the University of Miami. | Q38497194 | ||
| Mucosal fibrosis in intestinal transplant biopsies correlates positively with the development of chronic rejection | Q38509156 | ||
| Contribution of early acute rejection episodes to chronic rejection in a rat kidney retransplantation model | Q38553742 | ||
| The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review. | Q38568380 | ||
| Long-Term Fish Oil Lipid Emulsion Use in Children With Intestinal Failure-Associated Liver Disease | Q38768064 | ||
| An overview of EU and USA intestinal transplant current activity | Q38824350 | ||
| Non-HLA Antibodies May Accelerate Immune Responses After Intestinal and Multivisceral Transplantation | Q38834045 | ||
| Lessons learned in pediatric small bowel and liver transplantation from living-related donors | Q57130048 | ||
| Fifteen years’ experience of intestinal and multivisceral transplantation in the Nordic countries | Q59257785 | ||
| Innate Lymphoid Cells Groups 1 and 3 in the Epithelial Compartment of Functional Human Intestinal Allografts | Q60261586 | ||
| Intestinal transplantation in composite visceral grafts or alone | Q67544415 | ||
| Combined small bowel and liver transplantation in the rat: possible role of the liver in preventing intestinal allograft rejection | Q67980112 | ||
| Improved survival of heterotopic cardiac allografts in rats with dietary n-3 polyunsaturated fatty acids | Q68879230 | ||
| Infection-associated cellular activation accelerates chronic renal allograft rejection in rats | Q71098594 | ||
| Increased expression of interferon-gamma in a rat model of chronic intestinal allograft rejection | Q71393293 | ||
| Functional impairment of enteric smooth muscle and nerves caused by chronic intestinal allograft rejection regresses after FK506 rescue | Q71671209 | ||
| Pathology of human intestinal transplantation | Q71884840 | ||
| Prolonged in vivo administration of cyclosporine causes enteric smooth muscle hyperplasia in normal rat intestine and small bowel grafts | Q72057820 | ||
| Clinical course, morphology, and treatment of chronically rejecting small bowel allografts | Q72070266 | ||
| Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival | Q72121859 | ||
| Heat shock protein reactivity of lymphocytes isolated from heterotopic rat cardiac allografts | Q72601448 | ||
| Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection | Q72765616 | ||
| Prevention by liver transplantation of the graft-versus-host reaction and allograft rejection in a rat model of small bowel transplantation | Q72778729 | ||
| Small bowel transplantation and chronic rejection alter rat intestinal smooth muscle structure and function | Q72858965 | ||
| A rat small bowel transplant model of chronic rejection: histopathologic characteristics | Q73068828 | ||
| DAMP-Induced Allograft and Tumor Rejection: The Circle Is Closing. | Q38928826 | ||
| Persistence of hepatic fibrosis in pediatric intestinal failure patients treated with intravenous fish oil lipid emulsion. | Q38965783 | ||
| Characterization of the ileal microbiota in rejecting and nonrejecting recipients of small bowel transplants | Q39677699 | ||
| Long-Term Outcomes of Intestinal and Multivisceral Transplantation at a Single Center in Argentina | Q39826046 | ||
| Coexpression of the collagen-binding stress protein HSP47 gene and the alpha 1(I) and alpha 1(III) collagen genes in carbon tetrachloride-induced rat liver fibrosis | Q40513019 | ||
| The Leuven Immunomodulatory Protocol Promotes T-Regulatory Cells and Substantially Prolongs Survival After First Intestinal Transplantation | Q40731460 | ||
| Intestinal Graft Failure: Should We Perform the Allograft Enterectomy Before or With Retransplantation? | Q40782656 | ||
| Rejection of human intestinal allografts: alone or in combination with the liver | Q41031994 | ||
| The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation | Q41150961 | ||
| Liver inclusion improves outcomes of intestinal retransplantation in adults. [Corrected]. | Q41647132 | ||
| Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model | Q42094566 | ||
| Perioperative Infliximab Application Ameliorates Acute Rejection Associated Inflammation After Intestinal Transplantation | Q42846834 | ||
| Influence of immunosuppression on alloresponse, inflammation and contractile function of graft after intestinal transplantation | Q42965946 | ||
| Successful treatment with bortezomib of a refractory humoral rejection of the intestine after multivisceral transplantation. | Q43044456 | ||
| Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection | Q43166691 | ||
| Chronic morpho-functional damage as a consequence of transient ischemia/reperfusion injury of the small bowel | Q43200869 | ||
| Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation | Q43618136 | ||
| Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges | Q43760157 | ||
| Influence of donor brain death on chronic rejection of renal transplants in rats | Q43775985 | ||
| The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes | Q44174433 | ||
| Attenuation of rat chronic small bowel allograft rejection by n-3 polyunsaturated fatty acids is associated with reduced expression of graft IL-15. | Q44297966 | ||
| Intestinal transplant registry report: global activity and trends. | Q44853926 | ||
| Infectious complications after multivisceral transplantation in adults | Q45103088 | ||
| Cell stress response in rat chronic small bowel allograft rejection | Q45209052 | ||
| Combined liver-kidney transplants: allosensitization and recipient outcomes | Q45329810 | ||
| Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions | Q45342440 | ||
| Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation | Q45627897 | ||
| Histologic analysis of chronic rejection in small bowel transplantation: mucosal and vascular alterations | Q45807893 | ||
| Evidence that indefinite survival of small bowel allografts achieved by a brief course of cyclosporine or FK506 is not due to systemic hyporesponsiveness. | Q46162411 | ||
| Chronic kidney disease--a common and serious complication after intestinal transplantation | Q46486890 | ||
| Induction of immunological tolerance by porcine liver allografts | Q47792524 | ||
| Intragraft heat shock protein-60 expression after small bowel transplantation in the mouse | Q47863098 | ||
| Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter? | Q47880758 | ||
| Up-regulation of HSP47 in the mouse kidneys with unilateral ureteral obstruction | Q47906233 | ||
| Belgian multicenter experience with intestinal transplantation. | Q48037071 | ||
| The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation | Q49799963 | ||
| Intestinal regeneration, residual function and immunological priming following rescue therapy after rat small bowel transplantation. | Q50503625 | ||
| Effectiveness of Bortezomib in a Patient With Acute Rejection Associated With an Elevation of Donor-Specific HLA Antibodies After Small-Bowel Transplantation: Case Report. | Q50858859 | ||
| Long-term Persistence of Innate Lymphoid Cells in the Gut After Intestinal Transplantation. | Q51017443 | ||
| Impacts of donor-specific anti-HLA antibodies and antibody-mediated rejection on outcomes after intestinal transplantation in children. | Q51192960 | ||
| Effects of omega-3 fatty acids in rat allogenic small intestinal transplantation. | Q52106619 | ||
| Clinical relevance of the de novo production of anti-HLA antibodies following intestinal and multivisceral transplantation. | Q52881666 | ||
| C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection. | Q53225887 | ||
| Prospective Monitoring of Donor-specific Anti-HLA Antibodies After Intestine/Multivisceral Transplantation: Significance of De Novo Antibodies. | Q53714276 | ||
| Abnormal CX3CR1⁺ lamina propria myeloid cells from intestinal transplant recipients with NOD2 mutations. | Q54330085 | ||
| Meeting Report of the XIV International Small Bowel Transplant Symposium: Summary of Presentations, Workshops, and Debates From a Comprehensive Meeting on Intestinal Failure, Rehabilitation, and Transplantation, Buenos Aires, Argentina, June 10-13, 2 | Q56969839 | ||
| Mortality after steroid-resistant acute cellular rejection and chronic rejection episodes in adult intestinal transplants: report from a single center in induction/preconditioning era | Q56978416 | ||
| Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience | Q56989567 | ||
| Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation | Q56995194 | ||
| P577 | publication date | 2018-01-11 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Chronic Rejection After Intestinal Transplant: Where Are We in Order to Avert It? |
Search more.